b'Letter from the Program Co-DirectorAs I was trying to compose my thoughts Despite the challenges of COVID-19, our team has continued to for this newsletter, I decided to go back forge ahead with ongoing initiatives. On the gynecologic oncology and read our spring newsletter again. It hasfront, the most significant development has been the launch of only been six months since it was published,GYOEDU.org website as an educational tool for residents, fellows but it feels like I wrote my last update aand practitioners. If you havent seen the website yet, I encourage millennium ago. Things have changedyou to do so today. You will find lectures from prominent leaders Dr.ShitanshuUppaldrastically since March 2020, and thein the field of gynecologic oncology, as well as summaries of key Program Co-Director COVID-19 pandemic and protests againststudies in our field. If you would like to give a lecture, please reach police brutality are still ongoing. We have continued to endure thisout to our team.crisis and are emerging with a stronger resolve and commitmentOur partnership with the Michigan Surgical Quality Collaborative to help underprivileged communities. (MSQC) is moving forward. We will be providing a more in-depth This pandemic has exposed the vulnerabilities of our system.update on this during our MOQC Gynecologic Oncology Fall There has never been a greater need to fight injustice andBiannual Meeting.systemic racism. Our team at Michigan Oncology QualityFinally, the first episode of the Ovarian Cancer Podcast series is Consortium, along with all of you, is committed to adoptingnow available for you to listen. You can access this podcast here: anti-racist policies and doing our best to take care of those whomoqc.org/initiatives/gynecologic-oncology/ovarian-cancer-resources need us the most in these difficult times. Dr. Griggs has led several efforts in our health systems and across several CQIs to helpA huge shout out to Vanessa Aron for turning this idea into a reality.us achieve our goal of equity and diversity; for those of you who are interested in participating in these efforts, please stay tuned. MiGHT Family Health HistoryPractice SpotlightTool ProjectIn June of 2020, Jennifer Griggs, MD, MPH, Elena Stoffel, MD, MPH,TheCoordinatingCenterwelcomes and Ken Resnicow, PhD, were awarded a grant by the NationalDr. Christopher Hummel, the newest Institutes of Health/National Cancer Institute for the MichigangynecologiconcologistatSpectrum Genetic Hereditary Testing (MiGHT) study. The goal of this project Health Center.is to save lives by identifying patients and family members who have inherited susceptibility to cancer. The Research, Publication,Dr. Hummel is an obstetrician and gynecologist specializing and Data Integration Committee of MOQC approved this project. in gynecologic oncology. He received his medical degree The MiGHT project will do this by increasing both the collection from Lake Erie College of Osteopathic Medicine in Erie, of a comprehensive family history and referral of high-risk patientsPennsylvania. He went on to complete his obstetrics and to genetic testing and counseling. We will work with you and yourgynecology residency at York Memorial Hospital and his practices to make it simpler to collect your patients family historygynecologic oncology fellowship at York Cancer Center, through use of a validated, tablet-based family health historywhich are both located in York, Pennsylvania. Dr. Hummel survey (FHHS) tool in oncology practices. The FHHS asks patientsenjoysspendingtimewithfamily,hiking,traveland questions about the cancer history of first and second degreebeing outdoors. relatives and the ages at which they developed cancer and then makes the responses and a pedigree immediately available to you. Dr. Hummel joins Dr. Charles Harrison and Dr. Leigh If you are part of a MOQC practice, you will be asked to participateSeamoninthegynecologiconcologypracticeatin MiGHT and will be provided with the FHHS tool and assistanceSpectrum.SpectrumHealthtakesprideinfocusingon with incorporating it into clinical practice. The first practices willa collaborative approach for treating womens cancers, introduce the FHHS in early 2021. MOQC practices will then have combining the best in medicine, science, research and a staggered introduction to using the FHHS tool over the next 3care to provide the best possible outcome and years. Data from the QOPI measure looking at the proportion ofexperience for each and every patient.patients with a complete family history documented will be usedto assess the impact of introducing the new FHHS tool.If you have any questions about the MiGHT project, pleasereach out to the MOQC project coordinator ShaynaWeinershaynaw@med.umich.edu.2'